Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BAT3 was first characterized as part of a cluster of genes located within the human major histocompatibility complex class III region. Additionally we are shipping Large Proline-Rich Protein BAT3 Kits (11) and Large Proline-Rich Protein BAT3 Proteins (8) and many more products for this protein.
Showing 10 out of 72 products:
Human Polyclonal BAT3 Primary Antibody for EIA, WB - ABIN950609
Minami, Hayakawa, Kagawa, Yanagi, Yokosawa, Kawahara: BAG-6 is essential for selective elimination of defective proteasomal substrates. in The Journal of cell biology 2010
Show all 5 references for 950609
Mouse (Murine) Polyclonal BAT3 Primary Antibody for EIA, WB - ABIN400989
Desmots, Russell, Lee, Boyd, McKinnon: The reaper-binding protein scythe modulates apoptosis and proliferation during mammalian development. in Molecular and cellular biology 2005
Human Polyclonal BAT3 Primary Antibody for ELISA, IHC - ABIN451797
Annunziata, Kleinberg, Davidson, Berner, Gius, Tchabo, Steinberg, Kohn: BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Arabidopsis BAG6 (AtBAG6) knockout lines exhibited a pronounced enhancement of susceptibility to the necrotrophic fungal pathogen Botrytis cinerea.
Targeted inactivation of BAGP1 or APCB1 results in the blocking of BAG6 processing and loss of fungal resistance.
BAT3 negatively regulates lipopolysaccharide-induced NF-kappaB (show NFKB1 Antibodies) signaling through TRAF6 (show TRAF6 Antibodies).
The observations suggest a mechanism whereby the BAG6 ubiquitin-linked domain provides a platform for discriminating substrates with shorter hydrophobicity stretches as a signal for defective proteins.
we found BAG6 to be dispensable in antigen processing
Data indicate that the BAGS domain of BAG6 (Bcl-2-associated athanogene 6) interacts with the C-terminal domain of Ubl4a (ubiquitin-like protein 4a (show UBL4A Antibodies)).
BAG6 also decreases the EP300 (show EP300 Antibodies) dependent-acetylation of ATG5 (show ATG5 Antibodies), ATG7 (show ATG7 Antibodies), and LC3 (show MAP1LC3A Antibodies)-I, posttranslational modifications that inhibit autophagy.
BAT3 tightly controls autophagy by modulating p300 (show NOTCH1 Antibodies) intracellular localization, affecting the accessibility of p300 (show NOTCH1 Antibodies) to its substrates, p53 (show TP53 Antibodies) and ATG7 (show ATG7 Antibodies).
Mycobacterium tuberculosis-derived protein ESAT-6 (Rv3875) induced transient increase in the expression and release of BAT3 in macrophages.
Bat3 interacts with the nuclear phosphatase small C-terminal domain phosphatase (SCP) 2 (show CRISP3 Antibodies), which terminates BMP signaling by dephosphorylating Smad1 (show SMAD1 Antibodies)/5/8.
Scythe is critical for viability and normal development, probably via regulation of programmed cell death and cellular proliferation
Scythe regulates apoptosis-inducing factor (show AIFM1 Antibodies) stability during endoplasmic reticulum stress-induced apoptosis
BAG6 co-localizes with HSPA2 (show HSPA2 Antibodies) in huinan testicular germ cells and epididymal spermatozoa, moving from the equator to the anterior head during capacitation and stably interacting with HSPA2 (show HSPA2 Antibodies). In zona pellucida binding defect infertility, BAG6 is lacking.
VNTR in the coding region of the FAM46A gene, FAM46A rs11040 SNP and BAG6 rs3117582 SNP are associated with susceptibility to tuberculosis
BAG6 rs3117582 SNP was associated with non small cell lung cancer in the Norwegian subjects and the combined Croatian-Norwegian subjects corroborating the earlier finding that BAG6 rs3117582 SNP was associated with lung cancer in Europeans.
The BAT2 (show BAT2 Antibodies)/BAT3 polymorphisms and specifically the A/C haplotype may represent a novel immunogenetic factor associated with graft rejection in patients undergoing allo-HSCT.
Data show that molecular chaperone (show HSP90AA1 Antibodies) BAG6_ubiquitin-like domain (UBL) and ubiquitin-like 4A (show UBL4A Antibodies) UBL4A_UBL compete for the same binding site on N-terminal dimerisation domain of SGTA (show SGTA Antibodies) protein (SGTA_NT).
This meta-analysis suggested that HLA-B-associated transcript 3 polymorphisms are risk factors for lung cancer.
Both TRC35 (show C7orf20 Antibodies) and Ubl4A (show UBL4A Antibodies) have distinct C-terminal binding sites on Bag6 defining a minimal Bag6 complex.
Exogenous BAG6 perturbs the function of the BAG6 complex at a stage subsequent to substrate recognition and polyubiquitylation, most likely the BAG6-dependent delivery of OpD (show FLNA Antibodies) to the proteasome.
This gene was first characterized as part of a cluster of genes located within the human major histocompatibility complex class III region. This gene encodes a nuclear protein that is cleaved by caspase 3 and is implicated in the control of apoptosis. In addition, the protein forms a complex with E1A binding protein p300 and is required for the acetylation of p53 in response to DNA damage. Multiple transcript variants encoding different isoforms have been found for this gene.
BAG family molecular chaperone regulator 6
, HLA-B-associated transcript 3
, large proline-rich protein BAG6
, large proline-rich protein BAT3
, protein Scythe
, HLA-B associated transcript 3
, HLA-B associated transcript-3
, protein G3
, Large proline-rich protein BAT3